85 results
Page 3 of 5
6-K
EX-5.1
ggpy3rr
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
hgc69c80dfvatflac2o
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
supmirp637hhhxz ujn
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
ft82ojue k8pdu
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
mxlglf t912
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
wcnkdhacuj 1an
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
0123 ogly
10 Jul 19
Prospectus supplement
8:18am
F-3
y5dlso0
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
2pcfq54 95s92y1s
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.1
nsjszv5e
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
m4thie st3b10za49
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
77a6xwczl68 3x0tvdk
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
27xkyh3244
27 Mar 19
Securities Purchase Agreement
8:32am